Coverage
-
May 27, 2015
The U.S. Food and Drug Administration acted permissibly when it approved generic versions of Otsuka Pharmaceutical Co. Ltd.'s antipsychotic Abilify despite remaining market exclusivity for the blockbuster product, a Maryland federal judge ruled Wednesday.
8 other articles on this case.
View all »